Logo image of USAR

USA RARE EARTH INC (USAR) Stock Fundamental Analysis

NASDAQ:USAR - Nasdaq - US91733P1075 - Common Stock - Currency: USD

9.3  +0.19 (+2.09%)

After market: 9.39 +0.09 (+0.97%)

Fundamental Rating

2

Taking everything into account, USAR scores 2 out of 10 in our fundamental rating. USAR was compared to 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of USAR have multiple concerns. USAR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

USAR had positive earnings in the past year.
USAR had a negative operating cash flow in the past year.
USAR Yearly Net Income VS EBIT VS OCF VS FCFUSAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

Looking at the Return On Assets, with a value of 32.73%, USAR belongs to the top of the industry, outperforming 97.40% of the companies in the same industry.
Looking at the Return On Equity, with a value of 112.13%, USAR belongs to the top of the industry, outperforming 99.35% of the companies in the same industry.
Industry RankSector Rank
ROA 32.73%
ROE 112.13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USAR Yearly ROA, ROE, ROICUSAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 40 60 80 100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for USAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USAR Yearly Profit, Operating, Gross MarginsUSAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

USAR has less shares outstanding than it did 1 year ago.
The debt/assets ratio for USAR is higher compared to a year ago.
USAR Yearly Shares OutstandingUSAR Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M
USAR Yearly Total Debt VS Total AssetsUSAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

USAR has an Altman-Z score of 31.40. This indicates that USAR is financially healthy and has little risk of bankruptcy at the moment.
USAR's Altman-Z score of 31.40 is amongst the best of the industry. USAR outperforms 89.61% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that USAR is not too dependend on debt financing.
USAR has a Debt to Equity ratio (0.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 31.4
ROIC/WACCN/A
WACCN/A
USAR Yearly LT Debt VS Equity VS FCFUSAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.02 indicates that USAR may have some problems paying its short term obligations.
The Current ratio of USAR (0.02) is worse than 95.45% of its industry peers.
A Quick Ratio of 0.02 indicates that USAR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.02, USAR is doing worse than 95.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
USAR Yearly Current Assets VS Current LiabilitesUSAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.85% over the past year.
EPS 1Y (TTM)36.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -46.53% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-122.93%
EPS Next 2Y-46.73%
EPS Next 3Y-46.53%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USAR Yearly Revenue VS EstimatesUSAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 50M 100M 150M
USAR Yearly EPS VS EstimatesUSAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 32.07 indicates a quite expensive valuation of USAR.
Based on the Price/Earnings ratio, USAR is valued a bit cheaper than 63.64% of the companies in the same industry.
When comparing the Price/Earnings ratio of USAR to the average of the S&P500 Index (25.82), we can say USAR is valued slightly more expensively.
USAR is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 32.07
Fwd PE N/A
USAR Price Earnings VS Forward Price EarningsUSAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAR Per share dataUSAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

A cheap valuation may be justified as USAR's earnings are expected to decrease with -46.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.73%
EPS Next 3Y-46.53%

More info and screens

0

5. Dividend

5.1 Amount

USAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

USA RARE EARTH INC

NASDAQ:USAR (5/23/2025, 9:01:15 PM)

After market: 9.39 +0.09 (+0.97%)

9.3

+0.19 (+2.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)N/A N/A
Inst Owners25.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change1.74%
Market Cap963.57M
Analysts82.86
Price Target15.3 (64.52%)
Short Float %2.4%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 32.07
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 136.79
P/tB 136.79
EV/EBITDA N/A
EPS(TTM)0.29
EY3.12%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 32.73%
ROE 112.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 31.4
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.08%
EPS Next Y-122.93%
EPS Next 2Y-46.73%
EPS Next 3Y-46.53%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-312.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.53%
OCF growth 3YN/A
OCF growth 5YN/A